Abstract
Drug delivery systems for gene transfer are called ‘vectors’. These systems were originally invented as a delivery system for the transfection in vitro or in vivo. Several vectors are then developed for clinical use of gene medicines and currently some of them are approved as animal drugs. Conventional drug delivery system generally consists of approved (existing) materials to avoid additional pre-clinical or clinical studies. However, current vectors contain novel materials to improve an efficacy of gene medicines. Thus, these vectors have functions more than a mere delivery of active ingredients. For example some vectors have immunological functions such as adjuvants in vaccines. These new types of vectors are called ‘intelligent’ or ‘innovative’ vector system’, since the concept or strategy for the development is completely different from conventional drug delivery systems. In this article, we described a current status of ‘intelligent gene transfer vectors and discussed on the potentials of them.
Keywords: Drug delivery system, gene medicine, gene therapy, gene transfer, nucleic acid medicine, vector system, ‘intelligent’ or ‘innovative’ vector system
Current Topics in Medicinal Chemistry
Title:Novel Gene Transfer Systems: Intelligent Gene Transfer Vectors for Gene Medicines
Volume: 12 Issue: 15
Author(s): Toshihiro Nakajima
Affiliation:
Keywords: Drug delivery system, gene medicine, gene therapy, gene transfer, nucleic acid medicine, vector system, ‘intelligent’ or ‘innovative’ vector system
Abstract: Drug delivery systems for gene transfer are called ‘vectors’. These systems were originally invented as a delivery system for the transfection in vitro or in vivo. Several vectors are then developed for clinical use of gene medicines and currently some of them are approved as animal drugs. Conventional drug delivery system generally consists of approved (existing) materials to avoid additional pre-clinical or clinical studies. However, current vectors contain novel materials to improve an efficacy of gene medicines. Thus, these vectors have functions more than a mere delivery of active ingredients. For example some vectors have immunological functions such as adjuvants in vaccines. These new types of vectors are called ‘intelligent’ or ‘innovative’ vector system’, since the concept or strategy for the development is completely different from conventional drug delivery systems. In this article, we described a current status of ‘intelligent gene transfer vectors and discussed on the potentials of them.
Export Options
About this article
Cite this article as:
Nakajima Toshihiro, Novel Gene Transfer Systems: Intelligent Gene Transfer Vectors for Gene Medicines, Current Topics in Medicinal Chemistry 2012; 12 (15) . https://dx.doi.org/10.2174/156802612803531487
DOI https://dx.doi.org/10.2174/156802612803531487 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs
Current Drug Targets - Infectious Disorders Pyridines and Imidazopyridines with Medicinal Significance
Current Topics in Medicinal Chemistry Selective Inhibition of SIRT2 Improves Outcomes in a Lethal Septic Model
Current Molecular Medicine Graphene Oxide as Scaffolds for Stem Cells: An Overview
Current Molecular Medicine Structure-Editing of Nucleic Acids for Selective Targeting of RNA
Current Topics in Medicinal Chemistry Cytochrome P450 Structure, Function and Clinical Significance: A Review
Current Drug Targets Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Patent Selections
Recent Patents on Anti-Infective Drug Discovery Development ofNovel Compounds to Treat Autoimmune and Inflammatory Diseases and Graft Versus Host Reactions
Endocrine, Metabolic & Immune Disorders - Drug Targets Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Is Biotechnological Next-Generation Therapeutics Promising Enough in Clinical Development to Treat Advanced Colon Cancer?
Current Pharmaceutical Biotechnology Privileged Structures: Applications in Drug Discovery
Combinatorial Chemistry & High Throughput Screening Data Reduction Methods for Application of Fluorescence Correlation Spectroscopy to Pharmaceutical Drug Discovery
Current Pharmaceutical Biotechnology Efficacy and Safety of Inhaled and Intranasal Corticosteroids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Biological Activities of the Essential Oil of Zanthoxylum armatum DC. Leaves
The Natural Products Journal Genomics of Metal Stress-Mediated Signalling and Plant Adaptive Responses in Reference to Phytohormones
Current Genomics Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET
Current Pharmaceutical Design Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
Current Medicinal Chemistry Serous BMP8A has Clinical Significance in the Ultrasonic Diagnosis of Thyroid Cancer and Promotes Thyroid Cancer Cell Progression
Endocrine, Metabolic & Immune Disorders - Drug Targets